Medicine is on the brink of losing its human touch in 2026 — and this shift is more profound than most realize. Imagine arriving early to your doctor’s office, exhausted before the appointment even begins, only to be handed a thick stack of forms repeating questions about your health, medications, surgeries, and daily activities that you answered just last year and the year before. You’re asked to remember three unrelated words and even draw a clock — cognitive tests meant to gauge your brain function. You have to rewrite your family history, despite no changes since your last visit.
Sounds frustrating, right? But here’s where it gets controversial: this isn’t about improving your care. Instead, it's about filling boxes to ensure the visit counts toward quality metrics — if any part of the paperwork is incomplete, the appointment doesn’t “count.” By the time the doctor actually sees you, the visit resembles a bureaucratic exam rather than personalized care.
Patients often tell me that these annual wellness visits feel intrusive and redundant, as if they’re ticking off checklists rather than addressing real concerns. Yet, what most don’t realize is that this onerous paperwork is just the visible tip of a far deeper problem.
As of late 2025, healthcare systems nationwide are scrambling to overhaul their workflows in preparation for 2026, driven by new mandates from CMS (Centers for Medicare & Medicaid Services) and Medicare Advantage plans finalizing stricter quality benchmarks. Electronic medical records (EMRs) are being updated with mandatory fields, reminders, and alerts that cannot be bypassed. Missing even early performance targets in 2026 will trigger significant consequences — not easily corrected later. Because Medicare Advantage plans incorporate these requirements into their 2026 Star Ratings projections, health systems must operate as though these rules are already set in stone. This isn’t your typical year-end tweak; it’s a seismic shift with far-reaching effects.
The quality measures my department oversees for 2026 look dramatically different than those from just a year ago. Programs tied directly to Medicare Advantage Star Ratings — and by extension the reimbursements we receive — have surged to paramount importance. The new model broadens the number of tracked measures, expands which activities qualify for value-based incentives, and places greater emphasis on clinician-driven tasks such as annual wellness visits, diabetes management, kidney screening, statin prescriptions, medication adherence, and cancer screenings.
To adapt, healthcare protocols have been entirely redesigned. Metrics that barely registered last year now dictate staffing levels, appointment scheduling, documentation priorities, and how resources are allocated. For the first time in my career, I’m witnessing care pathways crafted primarily not around patient needs but around meeting scoring criteria.
Here’s the kicker: 2026’s targets combine higher benchmarks, more stringent scoring, and the removal of clinician discretion. Cutoffs for statin adherence, diabetes control, blood pressure management, cancer screenings, and preventive care are climbing—sometimes by double digits. Many plans have warned clinics that maintaining four- or five-star ratings in 2026 will require “dramatically higher closure rates.” In other words, a clinic delivering identical care to 2025 could slip to just three stars next year with no change in actual practice. This level of disconnect between care and rating is unprecedented.
Another twist involves measures formerly considered to be for “reporting only.” These are now fully weighted in Star Ratings and reimbursements—a shift phased in gradually by CMS but now fully operational in 2026. The cushion clinicians once had is disappearing. What’s documented is now graded, with financial repercussions.
The rigidity of the system goes even deeper. Let’s say a patient gets a mammogram or colonoscopy at another facility. If that result isn’t documented in my electronic record, it’s marked as missing — counted as a failure — regardless of whether the screening followed recommended guidelines. Diabetes scores similarly penalize high A1C values above 9 percent regardless of context. While optimal diabetes management ideally keeps A1C below this threshold, countless real-world factors such as the high cost of insulin, food insecurity, low health literacy, transportation challenges, mental health struggles, or simply life’s overwhelming demands affect control. None of these underlying barriers influence the scorecard. The final number alone dictates success or failure—and in 2026 the financial penalty tied to that number has never been harsher.
Meanwhile, the narrow grounds for exceptions remain unchanged. For example, regarding statin medication adherence, the only allowed exclusions involve allergies, severe adverse reactions, or terminal illness. If a capable adult patient refuses treatment after a well-informed discussion, that decision is invisible to the quality program. No current system acknowledges informed refusal as an acceptable clinical outcome.
In previous years, this caused frustration; in 2026, it results in penalties. Last year, clinicians might have been gently nudged to meet metrics. Next year, they face punishment for honoring patient autonomy.
Take statins as an example: a patient has to fill the prescription twice within a calendar year to meet the metric. A 76-year-old who declines the medication will count as a failure—and next year, that failure’s cost soars. Physicians who prioritize respecting patients’ values risk damaging their scores. Those who push medications purely to hit metrics will meet targets.
This sets up an impossible moral dilemma for clinicians: Should they honor individual patient choices or protect their healthcare organization from harsh financial consequences? No metric can resolve this ethical conflict.
The annual wellness visit starkly exposes this gap. Originally designed to focus on prevention, it has ballooned into a checklist exercise. In multiple systems, including my own, these required visits for 2026 include many mandatory fields aligned to the new scoring system—not necessarily new clinically important areas.
Patients often feel swamped by the paperwork and protocols; doctors find the visit disconnected from the actual reasons patients seek care. The more the visit expands to satisfy bureaucratic demands, the less time remains for meaningful conversations. We are mistaking filling forms for delivering quality care and equating compliance with true health improvement.
There is still time for Congress and CMS to intervene. CMS has a very limited window—days rather than weeks—to address the biggest flaw: the lack of a patient autonomy exclusion within quality measures. The solution is straightforward: allow clinicians to document when a patient declines recommended intervention following an informed discussion. This change would not lower care standards.
We must decide whether to build a healthcare system that rewards compliance or one that respects patients as individuals. We cannot fully achieve both. What we choose in 2026 will decide if medicine remains a human-centered profession or melts into a compliance-driven industry masquerading as care.
Ryan Nadelson, MD, chairs internal medicine at Northside Hospital Diagnostic Clinic in Gainesville, Georgia.
—
What do you think? Should medicine prioritize clinical scores or patient autonomy? Could there be a way to balance both, or is this an unavoidable trade-off? Share your thoughts and experiences below.
